Clinical Trials
Study Title:
A Phase 3, Randomized, Double Blind, Adaptive, Placebo/Paclitaxel Controlled Study of AVB S6 500 in Combination With Paclitaxel in Patients With Platinum Resistant Recurrent Ovarian Cancer
For more information about the trial above please contact the study team:
|